All Articles

As Disc Medicine nears a potential drug launch, its new HR chief hire reveals a critical strategy for navigating biotech's intense talent wars.

Sonos adds leaders from Meta, e.l.f. Beauty, and Pandora to its board, signaling a strategic push into AI, platform growth, and financial discipline.

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

Retail giant Grupo Chedraui unveils ambitious growth in Mexico while its US arm braces for immigration policy impacts, betting on efficiency to drive profits.

FS Specialty Lending Fund declared a distribution yielding 11.7%. We explore the alternative credit strategy and risks behind this eye-catching income play.

A new multi-year deal ensures thousands of Anthem members in Georgia retain access to a top GI provider, highlighting a new era of healthcare collaboration.

Papa Johns is overhauling 3,200 U.S. restaurants with PAR Technology's AI-native platform, promising a faster, smarter era for pizza operations.

Bitdeer reports a massive 339% surge in Bitcoin mining while aggressively expanding its AI cloud services with cutting-edge NVIDIA GB200 GPUs.

The home goods giant partners with Google on an open standard, enabling direct checkout from AI search and heralding a new era of agentic commerce.

ServiceNow executive Paul Fipps joins NetApp's board, bringing deep AI and customer ops expertise to accelerate the company's intelligent data strategy.

The AI health-tech leader achieved profitability and massive growth in 2025, expanding its reach to nearly 2,000 hospitals and doubling its life sciences arm.

As AGNC prepares its Q4 2025 earnings report, all eyes are on its dividend sustainability and risk strategies in a new era of Federal Reserve easing.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

The strategic acquisition of 70-year-old Stamford Tent by New York Tent's parent company signals a major consolidation in the booming Northeast event market.

New rules will soon require frequent certificate renewals. A new partnership aims to help Aussie firms automate, as manual processes become impossible.

A joint investment will renew 715 affordable units, offering immediate relief to residents but highlighting the vast scale of the region's housing crisis.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

With new federal guidelines backing whole foods, programs delivering 'prescription produce' are proving they can cut healthcare costs and fight chronic disease.

Pimicotinib, a once-daily pill for tenosynovial giant cell tumor, gains FDA review, offering new hope for patients beyond invasive surgery.

Accelint has won a key role in the MDA's $151B SHIELD program, signaling a major shift toward AI and autonomous systems in national missile defense.